Biotech

All Articles

Turnstone gives up 60%, shakes up C-suite to stretch out cash money

.Turnstone Biologics is actually lessening its own headcount through 60% and also shocking its own C...

Gilead gives up on $15M MASH bet after mulling preclinical records

.In a year that has observed an approval and a raft of readouts for metabolic dysfunction-associated...

Texas biotech centers cancer cells pact, pins really hopes on being overweight

.Alaunos Rehabs is actually axing a deal with Precigen, losing hope licensing rights to an individua...

Capricor portions extra data for DMD therapy after launching BLA

.Capricor Therapies is actually taking a victory tour for their stage 2 Duchenne muscle dystrophy (D...

FDA places Kezar lupus trial in grip observing 4 individual fatalities

.The FDA has positioned Kezar Lifestyle Sciences' lupus test on grip after the biotech hailed four f...

Phase 3 Historian Rock test attacks SMA target, sending stockpile 200%

.A period 3 trial of Scholar Stone's back muscular atrophy (SMA) applicant has actually reached its ...

CAMP 4 is most up-to-date to eye IPO, while Upstream describe $182M plan

.RNA biotech CAMP4 Therapies has actually marked out think about a $67 million IPO, with inflammatio...

Galecto buys leukemia medicine, loses bone cancer property in pivot

.A year after the failing of an idiopathic pulmonary fibrosis prospect sent Galecto on a seek salvat...

Judo tosses down $100M to knock senseless renal disease

.Taking the mat is Judo Biography, an ambitious biotech armed with $100 million to cultivate oligonu...

AstraZeneca spends CSPC $100M for preclinical heart disease medication

.AstraZeneca has actually settled CSPC Pharmaceutical Group $one hundred thousand for a preclinical ...